Invention Grant
- Patent Title: Histone demethylase inhibitors
-
Application No.: US15996316Application Date: 2018-06-01
-
Publication No.: US10231957B2Publication Date: 2019-03-19
- Inventor: Young K. Chen , Michael Brennan Wallace
- Applicant: CELGENE QUANTICEL RESEARCH, INC.
- Applicant Address: US CA San Diego
- Assignee: CELGENE QUANTICEL RESEARCH, INC.
- Current Assignee: CELGENE QUANTICEL RESEARCH, INC.
- Current Assignee Address: US CA San Diego
- Agency: Wiley Rein LLP
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/437 ; C07D487/04 ; A61P35/00

Abstract:
The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted pyrrolopyridine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.
Public/Granted literature
- US20180271843A1 HISTONE DEMETHYLASE INHIBITORS Public/Granted day:2018-09-27
Information query